Close Menu
    Trending
    • Abu Dhabi advances climate adaptation tools
    • Uganda Ebola cases rise to 15 after six new infections
    • Jangmi disrupts Tokyo flights and rail services
    • Punjab wildfire chars 3,037 hectares in Kotli Sattian
    • UAE and IAEA review nuclear safety after Barakah attack
    • Tokyo market splits as Nikkei sets closing record
    • Graid Technology Launches VROC(TM) by Graid Technology with 24-Month Roadmap and Tier 1 OEM Support
    • Resin Solutions LLC Introduces “Stratix(TM)” Brand Architecture for Products Serving the Aerospace and Defense Applications
    • Home
    • Contact Us
    Africa News HoundAfrica News Hound
    Saturday, June 6
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Africa News HoundAfrica News Hound
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Related Posts

    Graid Technology Launches VROC(TM) by Graid Technology with 24-Month Roadmap and Tier 1 OEM Support

    June 2, 2026

    Resin Solutions LLC Introduces “Stratix(TM)” Brand Architecture for Products Serving the Aerospace and Defense Applications

    June 1, 2026

    OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value

    May 27, 2026

    AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform

    May 19, 2026

    Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

    May 15, 2026

    Agnete Kirk Kristiansen Appointed Chair of the LEGO Foundation

    May 13, 2026
    Latest News

    Abu Dhabi advances climate adaptation tools

    June 5, 2026

    Environment Agency – Abu Dhabi is advancing climate adaptation, biodiversity protection and resource monitoring across the emirate.

    Uganda Ebola cases rise to 15 after six new infections

    June 3, 2026

    Uganda confirmed six new Ebola cases, raising the outbreak total to 15 as health teams trace contacts and care for admitted patients.

    Jangmi disrupts Tokyo flights and rail services

    June 3, 2026

    Severe Tropical Storm Jangmi weakens after landfall but keeps Tokyo on alert with heavy rain, flight cancellations and rising rivers.

    Punjab wildfire chars 3,037 hectares in Kotli Sattian

    June 3, 2026

    Satellite data shows the Kotli Sattian forest fire burned 3,037 hectares across 25 sites, damaging Punjab pine cover during heatwave conditions.

    © 2026 Africa News Hound | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.